Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation

Diabetologia

Volumn 44, Issue 9, 2001, Pages 1118-1120

  Chalmers, J ^a   Cooper, M ^a   Ferrannini, E ^a   Glasziou, P ^a   Grobbee, D ^a   Hamet, P ^a   Harrap, S ^a   Liu, L ^a   MacMahon, S ^a   Mancia, G ^a   Marre, M ^a   Matthews, D ^a   Mogensen, C ^a   Neal, B ^a   Yu Pan, C ^a   Poulter, N ^a   Rodgers, A ^a   Williams, B ^a   Woodward, M ^a   Collins, R ^a   Sandercock, P ^a   Sleight, P ^a   Holman, R ^a   Fulcher, G ^a   Pollock, C ^a   Celermajer, D ^a   Watson, J ^a   Harrisberg, B ^a   Currie, R ^a   Girgis, S ^a   Jayne, K ^a   Monaghan, H ^a   Patel, A ^a   Richens, A ^a   Gray, B ^a   Milne, A ^a   Adderkin, A ^a   Bak, A ^a   Flett, S ^a   De Guise, D ^a   Jetses, E ^a   Reid, J ^a   Stolk, R ^a   Wang, W ^a   Williams, F ^a   Zou, X ^a   more..

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Blood glucose; Blood pressure; Cardiovascular disease; Controlled clinical trial; Diabetes mellitus; Diabetic nephropathy; Diabetic retinopathy

Indexed keywords

GLICLAZIDE; INDAPAMIDE; PERINDOPRIL;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CLINICAL PROTOCOLS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIURETICS; GLICLAZIDE; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; INDAPAMIDE; MIDDLE AGED; MULTICENTER STUDIES; PERINDOPRIL; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; SULFONYLUREA COMPOUNDS;

EID: 17944382481     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250100612     Document Type: Article

References (10)

1. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections
2. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
3. Long-term complications of diabetes mellitus
4. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36) prospective observational study
5. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
6. Efficacy of diuretics and beta-blockers in diabetic hypertensive patients: Results from a meta-analysis
7. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
8. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials
9. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
10. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)